期刊文献+

组织工程细胞片构建方法

CONSTRUCTION METHODS OF TISSUE ENGINEERED CELL SHEET
原文传递
导出
摘要 目的综述组织工程细胞片构建方法的研究进展并展望前景。方法广泛查阅近年来有关构建组织工程细胞片的研究与应用的文献,选择常见方法分别进行阐述。结果通过组织工程细胞片方法构建的组织,可以打破传统组织工程方法对组织工程发展的限制。目前构建组织工程细胞片的方法主要包括温敏培养皿、胶原凝胶、磁力组织工程、表面粗糙的颗粒单分子层及聚合电解质。结论 组织工程细胞片构建方法可行,具有广泛的应用前景。 Objective To summarize the recent progress of construction methods of engineered cell sheet and to forecast the possible prospect. Methods The recent original articles about investigation and application of engineered cell sheet were reviewed. Several common methods were selected and expounded. Results The construction methods of engineered cell sheet mainly include temperature-responsive culture dish, salmon atelocollagen, magnetic force, surface roughness, and polyelectrolytes, which may overcome the limits of traditional tissue engineering methods. Conclusion The construction methods of engineered cell sheet are feasible and have a bright future in the clinical application.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2011年第6期741-744,共4页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 组织工程 细胞片 构建 Tissue engineering Cell sheet Construction
  • 相关文献

参考文献33

  • 1Vacanti ]P. Beyond transplantation. Third annual Samuel lason M/xter lecture. Arch Surg, 1988, 123(5): 545-549.
  • 2Langer R, Vacanti IP. Tissue engineering. Science, 1993, 260(5110): 920-926.
  • 3Vacanti CA, Vacanti IP. The science of tissue engineering. Orthop Clin North Am, 2000, 31(3): 351-356.
  • 4Ohashi K, Park F, Kay MA. Hepatocyte transplantation: clinical and experimental application. 1 Mol Med, 2001, 79 ( 11 ): 617-630.
  • 5Horslen SP, Fox IJ. Hepatocyte transplantation. Transplantation, 2004, 77(10): 1481-1486.
  • 6Durdu S, Akar AR, Arat M, et al. Autologous bone-marrow mono- nuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg, 2006, 44(4): 732-739.
  • 7Nan)undappa A, Raza JA, Dieter RS, et al. Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart fail- ure: from bench to bedside. Expert Rev Cardiovasc Ther, 2007, 5(1): 125-131.
  • 8Engelmann MG, Franz WM. Stem cell therapy after myocardial infarc- tion: ready for clinical application? Curr Opin Mol Ther, 2006, 8(5): 396-414.
  • 9Gao LR, Wang ZG, Zhu ZM, et al. Effect of intracoronary transplanta- tion of autologous bone marrow-derived mononuclear cells on out- comes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol, 2006, 98(5): 597-602.
  • 10Beeres SL, Bax JJ, Dibbets P, et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic isch- emia. J Nucl Med, 2006, 47(4): 574-580.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部